COMMUNIQUÉS West-GlobeNewswire

BioVie Completes Patient Enrollment for its Phase 2a Clinical Trial of BIV201 in Refractory Ascites
06/02/2019
LOS ANGELES, Feb. 06, 2019 (GLOBE NEWSWIRE) -- BioVie Inc. (OTCQB: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for liver disease, announced today that it has [...]
Dan Boren, Former Oklahoma Member of Congress, Joins SoldierStrong Advisory Board
06/02/2019
STAMFORD, Conn., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Former Oklahoma congressman Dan Boren has joined the advisory board of SoldierStrong, a national nonprofit organization dedicated to improving the lives of the nation's [...]
Chimerix Announces Management Transition
06/02/2019
M. Michelle Berrey to Step Down as Chief Executive Officer DURHAM, N.C., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address life-threatening [...]
Catalyst Biosciences Announces Preclinical Proof-of-Concept Data of Gene Therapy Candidate CB 2679d-GT for the Treatment of Hemophilia B
06/02/2019
Results show a four-fold reduction in bleeding time for CB 2679d-GT and a three-fold improvement in clotting activity when compared with an AAV-encoding Padua vector Data presented at the 12 th Annual Congress of the [...]
ORYZON Announces Publication of a relevant paper for the therapeutic development of Iadademstat (ORY-1001) in Small Cell Lung Cancer (SCLC)
06/02/2019
Complete and durable tumor regression occurred with Iadademstat–induced NOTCH activation in a chemoresistant PDX model Further supports LSD1 inhibitors as a possible new and targeted therapy for SCLC Identifies the [...]
CareDx to Participate in BTIG 6th Annual Medical Technology, Life Science Tools and Diagnostics Conference
06/02/2019
BRISBANE, Calif., Feb. 06, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]
Inovalon Announces Fourth Quarter and Full Year 2018 Earnings Conference Call
06/02/2019
BOWIE, Md., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based platforms empowering data-driven healthcare, today announced that it will hold a [...]
Chembio Diagnostics Reports Preliminary Fourth Quarter and Full Year 2018 Revenue
06/02/2019
Announces Long-Term Strategic Targets MEDFORD, N.Y., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced [...]
Otonomy Announces Multiple Presentations at Association for Research in Otolaryngology Annual Meeting
06/02/2019
SAN DIEGO, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced multiple presentations at [...]
Codexis Announces Enzyme Supply Agreement with KYORIN Pharmaceutical for Overactive Bladder Drug Sold in Japan
06/02/2019
REDWOOD CITY, Calif., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS) announces a multi-year, exclusive supply agreement with KYORIN Pharmaceutical Co., Ltd. for the supply of a proprietary enzyme to be [...]
Kamada Announces Additional Interim Results from Phase 2 Proof of Concept Clinical Trial of Intravenous Alpha-1 Antitrypsin Treatment for Prevention of Lung Transplant Rejection
06/02/2019
Kamada’s IV-AAT demonstrated a trend towards improvements in multiple clinical outcomes, including days on mechanical ventilation post-transplant, pulmonary function at week 4 and week 48 post-transplant and six-minute [...]
BioCryst Strengthens Cash Position With Flexible $100 Million Debt Facility
06/02/2019
—New loan facility increases to $50 million to further extend cash runway— —Additional $30 million available at company option following positive Phase 3 APeX-2 data— —Another $20 million available at company option [...]
IRADIMED CORPORATION Announces Fourth Quarter 2018 Financial Results
06/02/2019
Reports fourth quarter 2018 revenue of $8.3 million Reports fourth quarter 2018 GAAP diluted EPS of $0.14 and non-GAAP diluted EPS of $0.16 Announces 2019 full year and first quarter financial guidance WINTER SPRINGS, [...]
Maverick Technology Solutions Award Winning ROSINBOMB™ Products Now Available Through Walmart
06/02/2019
Inclusion in Mega-Retailers offering Reflective of Product’s Mainstream Appeal and Acceptance. RENO, Nev., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Maverick Technology Solutions (OTC:MVRK), manufacturer of the highly acclaimed [...]
Capricor Resumes Dosing of Enrolled Patients in HOPE-2 Clinical Trial for Duchenne Muscular Dystrophy
06/02/2019
LOS ANGELES, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a clinical-stage biotechnology company, today announced that it has resumed per protocol dosing of patients already enrolled in its [...]
Axsome Therapeutics Receives FDA Agreement under Special Protocol Assessment (SPA) for the MOMENTUM Phase 3 Trial of AXS-07 in Migraine
06/02/2019
FDA agreement achieved on Phase 3 trial design, endpoints, and statistical approach Trial to enroll patients with a history of inadequate response to prior migraine treatments Trial initiation anticipated 1Q 2019 NEW [...]
MacroGenics Announces Positive Results from Pivotal Phase 3 SOPHIA Study of Margetuximab
06/02/2019
Margetuximab improved progression-free survival (PFS) compared to HERCEPTIN® (trastuzumab), when used in combination with chemotherapy in patients with HER2+ metastatic breast cancer BLA submission targeted for second [...]
The Board of Directors of Orion Corporation decided on an incentive plan for key persons
06/02/2019
ORION CORPORATION STOCK EXCHANGE RELEASE 6 FEBRUARY 2019 AT 12.45 PM EET The Board of Directors of Orion Corporation decided on an incentive plan for key persons The Board of Directors of Orion Corporation has decided [...]
Notice to the Annual General Meeting of Orion Corporation
06/02/2019
ORION CORPORATION STOCK EXCHANGE RELEASE 6 FEBRUARY 2019 at 12.30 p.m. EET Notice to the Annual General Meeting of Orion Corporation Notice is given to the shareholders of Orion Corporation to the Annual General Meeting [...]

Pages